Bilimsel Makale Arama | NeuralCipher AI

Kaynak kaydı

Enteric alpha-synuclein pathology in early-onset parkinsonism: Findings in a patient with SCA6.

Yun JY, Shin C, Kim SI, Kim JM, Lee JY, Chung SJ, Kim JW, Ahn TB, Park KW, Shin JH, Lee HJ, Kong SH, Suh YS, Kim HJ, Yang HK, Park SH, Jeon B.

Parkinsonism Relat Disord · 2026-10-20

DOI: 10.1016/j.parkreldis.2026.109025PMID: 42925589

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

ProSAAS overexpression arrests progression of motor deficits in a rat alpha-synuclein model of Parkinson's disease.

Shu Z, Lam HA, Videlock EJ, Lindberg I, Maidment NT.

Transl Neurodegener · 2026-10-16

DOI: 10.1186/s40035-026-00593-xPMID: 42888454

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Disease Course Map progression markers transfer from isolated REM sleep behavior disorder to non-RBD prodromal alpha-synucleinopathy: a PPMI study of 1,499 participants.

Fontana JC, Guimarães RL, de Faria AS, Braz KM, de Sá Pereira JF, Corrêa EM.

Parkinsonism Relat Disord · 2026-09-15

DOI: 10.1016/j.parkreldis.2026.108985PMID: 42743773

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Açık erişim

Alpha-synuclein and mitochondrial permeability transition pore interactions in rotenone-induced Parkinson's disease models: neuroprotective promise of cyclosporine A.

Singh S, Bir A, Thakur R, Chauhan A, Ghosh A, Mittal A, Nayak AK, Chakrabarti SS, Chakrabarti S.

Biochem Biophys Rep · 2026-09-10

DOI: 10.1016/j.bbrep.2026.102783PMID: 42755993

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Açık erişim

Seed amplification of released alpha-synuclein strains reveals genotype-specific differences in Parkinson's disease neurons.

Chedid J, Tang Y, Law K, Thompson L, Gambin Y, Sierecki E, Dzamko N.

Front Aging Neurosci · 2026-09-08

DOI: 10.3389/fnagi.2026.1917981PMID: 42774389

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

mTOR and STING Modulation Restores Hydrolase Activities and Decreases Alpha-Synuclein Pathology in the Cells from the Patients with GBA1-Associated Parkinson's Disease.

Usenko TS, Bezrukova AI, Basharova KS, Grigor'eva EV, Pavlova SV, Baydakova GV, Miliukhina IV, Zakharova EY, Pchelina SN.

Biochemistry (Mosc) · 2026-09-01

DOI: 10.1134/s0006297926601644PMID: 42830104

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

DNA Methylation of the <i>SNCA</i> Intron 1 and Alpha-Synuclein Expression in the CD45+ Blood Cells in Parkinson's Disease.

Lavrinova AO, Litusova EM, Dmitriev AA, Melnikova NV, Pidyurchina VN, Kulabukhova DG, Syreva OV, Miliukhina IV, Timofeeva AA, Berkovich OA, Pchelina SN, Emelyanov AK.

Biochemistry (Mosc) · 2026-09-01

DOI: 10.1134/s0006297926601735PMID: 42830106

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Açık erişim

Selective Neuronal Vulnerability to Alpha-Synuclein Pathology in Parkinson's Disease: A Critical Review of Mechanistic Rationale and Biomarker Stratification.

Livinț-Popa L, Nicolaie A, Mastaleru A, Socolov Ș, Mitrea M, Popescu G, Schreiner TG, Covali R, Cucu LE, Dima-Cozma LC, Cozma RS, Ciubotaru A, Olariu R, Ciurumelea CM, Borza LR, Vamanu A.

Med Sci (Basel) · 2026-08-17

DOI: 10.3390/medsci14040489PMID: 42646623

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Lack of genetic evidence for a role of SLC25A46 in alpha-synucleinopathies.

Yu H, Parlar SC, Senkevich K, Somerville EN, Zhang Z, Liu L, Teferra M, Ahmad J, Asayesh F, Rouleau GA, Gan-Or Z.

J Parkinsons Dis · 2026-08-06

DOI: 10.1177/1877718x261452773PMID: 42558006

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Integrated In Vivo and In Vitro Analysis of Alpha-Synuclein Aggregation and Neuroinflammatory Amplification in a Composite Parkinson's Disease Model.

He X, Qi H, Ma Z, Lv M, Gao S, Mei C, Yin J.

Neurochem Res · 2026-07-29

DOI: 10.1007/s11064-026-04840-5PMID: 42525302

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Açık erişim

Oligomeric Alpha-Synuclein from neural-derived extracellular vesicles as possible biomarkers of non-motor symptoms in Parkinson's disease.

Meloni M, Agliardi C, Salvatore A, Saibene FL, Marano M, Castagna A, Arcuri P, Zanzottera M, Guerini FR, Clerici M.

NPJ Parkinsons Dis · 2026-07-28

DOI: 10.1038/s41531-026-01474-wPMID: 42649220

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

From synaptic development to degeneration: a narrative review of small molecule strategies targeting alpha-synuclein in Parkinson's disease.

Khoo L, Ng KY, Chye CL, Ko Y, Lee JY, Koh Y, Tsen MT, Chye SM.

Metab Brain Dis · 2026-07-23

DOI: 10.1007/s11011-026-01911-yPMID: 42489942

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kayıtlar bilimsel kaynaklardan alınır. Bibliyografik kayıt sayısı, Türkçe çeviri veya editoryal onay sayısı değildir.

715 makale bulundu

Enteric alpha-synuclein pathology in early-onset parkinsonism: Findings in a patient with SCA6.

ProSAAS overexpression arrests progression of motor deficits in a rat alpha-synuclein model of Parkinson's disease.

Disease Course Map progression markers transfer from isolated REM sleep behavior disorder to non-RBD prodromal alpha-synucleinopathy: a PPMI study of 1,499 participants.

Alpha-synuclein and mitochondrial permeability transition pore interactions in rotenone-induced Parkinson's disease models: neuroprotective promise of cyclosporine A.

Seed amplification of released alpha-synuclein strains reveals genotype-specific differences in Parkinson's disease neurons.

mTOR and STING Modulation Restores Hydrolase Activities and Decreases Alpha-Synuclein Pathology in the Cells from the Patients with GBA1-Associated Parkinson's Disease.

DNA Methylation of the <i>SNCA</i> Intron 1 and Alpha-Synuclein Expression in the CD45+ Blood Cells in Parkinson's Disease.

Selective Neuronal Vulnerability to Alpha-Synuclein Pathology in Parkinson's Disease: A Critical Review of Mechanistic Rationale and Biomarker Stratification.

Lack of genetic evidence for a role of SLC25A46 in alpha-synucleinopathies.

Integrated In Vivo and In Vitro Analysis of Alpha-Synuclein Aggregation and Neuroinflammatory Amplification in a Composite Parkinson's Disease Model.

Oligomeric Alpha-Synuclein from neural-derived extracellular vesicles as possible biomarkers of non-motor symptoms in Parkinson's disease.

From synaptic development to degeneration: a narrative review of small molecule strategies targeting alpha-synuclein in Parkinson's disease.

Filtreler